Runway Growth Finance Eyes Accretive Boost From SWK Deal

Runway Growth Finance Corporation ((RWAY)) has held its Q4 earnings call. Read on for the main highlights of the call.

Runway Growth Finance’s latest earnings call struck a cautiously upbeat tone, as management highlighted strategic moves to strengthen the balance sheet and diversify risk, anchored by the pending SWK Holdings acquisition. While near-term earnings are under pressure from lower yields and prepayment-driven volatility, management stressed conservative underwriting, strong liquidity, and actions aimed at modestly boosting long-term earnings power.

Solid Investment Income Supports Dividend, Despite Declines

Runway Growth generated $30.0 million in total investment income and $11.6 million in net investment income in Q4, equating to $0.32 per share. The company maintained its base dividend at $0.33 per share and ended the year with roughly $0.65 per share of spillover income, providing some support for future distributions even as earnings softened.

Origination Activity Broadly Diversified Across Sectors

The firm completed seven investments in the quarter totaling $42.9 million, spanning technology, health care, and select consumer names. Highlights included a $20 million mobility deal, a $10 million consumer SPV, a $20 million commitment to Shield Therapeutics with $2 million funded at close, and $10.9 million of follow-on capital to existing portfolio companies.

SWK Deal Poised to Boost Diversification and Earnings

Management underscored the strategic importance of the SWK Holdings acquisition, expected to close in early April, which will add about 13 loans with a fair value near $235 million, plus equity and royalty positions. The transaction will increase health care and life sciences exposure, reduce average position size by roughly 22%, and is expected to deliver mid-single-digit run-rate NII accretion along with modest ROE expansion and better dividend coverage.

Robust Liquidity and Extended Debt Maturities

Runway Growth ended the period with $395.2 million of available liquidity, including $377 million of borrowing capacity, giving it ample room to fund commitments and the SWK portfolio. The company also issued $103.25 million of unsecured notes due 2031 at 7.25% and used proceeds to redeem higher-coupon near-term notes, extending its maturity ladder while working to reduce funding costs over time.

Credit Quality Remains Strong With Minimal Nonaccruals

The portfolio remains heavily weighted to first-lien senior secured loans, with only one loan, Domingo Healthcare, on nonaccrual. That position has a $4.8 million cost basis and $2.4 million fair value, representing just 0.25% of the portfolio at fair value, underscoring management’s emphasis on conservative credit and limited realized credit issues to date.

Improved Expense Discipline and Lower Realized Losses

Operating efficiency showed progress, as total operating expenses declined to $18.4 million from $21.0 million, a 12.4% reduction. Net realized losses on investments also improved materially, falling to $0.377 million from $1.3 million, suggesting tighter portfolio management and better loss containment.

Stable NAV Amid Slight Portfolio Contraction

Net assets stood at $484.9 million with NAV per share at $13.42 at year-end, a modest decline of about 1% from $13.55. The total investment portfolio’s fair value slipped 2% year-over-year to $927.4 million, reflecting repayment activity and earnings pressure but not a significant deterioration in asset quality.

Strengthening Pipeline and Sourcing From BC Partners

Management reported a healthier origination pipeline compared with the prior year, citing increased deal flow and enhanced sourcing through BC Partners. They expect SWK to further augment sourcing opportunities, and while acknowledging typical Q1 seasonality, they expressed measured optimism about 2026 deployment prospects.

Pressure on Investment Income and NII

Despite maintaining the dividend, the company faced notable headwinds as total investment income fell from $36.7 million to $30.0 million, an 18% decline. Net investment income dropped from $15.7 million to $11.6 million, a roughly 26% decrease, largely due to normalized prepayment fee income and the sequencing of portfolio activity.

Yield Compression From Lower Prepayment Income

The dollar-weighted average annualized yield on the debt portfolio fell to 14.2% in 2025 from 16.8% in the prior quarter, a 2.6 percentage-point compression. Year-over-year, yields declined more modestly from 14.7%, reflecting lower prepayment income and a shifting mix within the portfolio’s credit exposures.

Prepayments Driving Near-Term Volatility

During the quarter, Runway Growth saw two full and one partial repayment totaling $60.6 million, plus $2.2 million of scheduled amortization. While these repayments help recycle capital and de-risk the book, elevated prepayment activity has weighed on short-term earnings power and contributed to lower NII and a modest decline in portfolio fair value.

Timing Headwinds Around SWK Close and Debt Redemptions

Management flagged near-term softness in Q1 2026 earnings driven by a modest delay in the SWK transaction’s closing date. They also noted a one-time $0.02 per share headwind associated with the full redemption of 8% notes and partial redemption of 7.5% 2027 notes, which created a temporary drag even as it improves the capital structure longer term.

Modest NAV Erosion and Limited Capital Actions

Net assets slipped from $489.5 million to $484.9 million, a decline of about 0.9%, with NAV per share down around 1% to $13.42. The company was unable to use its stock repurchase program due to blackout restrictions tied to the pending SWK deal, delaying a potential lever for near-term shareholder value support.

Slight Uptick in Portfolio Risk Rating

The weighted average portfolio risk rating inched up to 2.45 from 2.42, a small move that indicates a modest shift in the credit mix. Management is addressing this by pursuing greater diversification and smaller average position sizes, initiatives that will be reinforced by the integration of SWK’s portfolio.

Guidance and Outlook Centered on SWK Integration

Looking ahead, Runway Growth expects the SWK acquisition to close in early April and push leverage to just under 1.2x, within a targeted 1.2x to 1.3x range and generally below 1.35x. Management anticipates mid-single-digit run-rate NII accretion, modest ROE expansion, better dividend coverage, and a reduced average position size, while cautioning that Q1 earnings will be soft due to closing timing and the one-time debt redemption charge.

Runway Growth’s earnings call painted a picture of a lender navigating near-term yield and earnings pressure while executing on balance-sheet and strategic moves aimed at smoothing volatility and enhancing long-term returns. For investors, the key watchpoints will be the successful integration of SWK, stabilization of yields, and the company’s ability to convert its robust pipeline into accretive growth without sacrificing credit quality.